The evolving scale and profile of cancer worldwide: Much ado about everything

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 1, 2016, Pages 3-5

  Bray, Freddie ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; GLOBAL HEALTH; HUMAN; INCIDENCE; MORTALITY; NEOPLASMS; PROGNOSIS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS;

CAUSE OF DEATH; GLOBAL HEALTH; HUMANS; INCIDENCE; MORTALITY; NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 84955266675     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-1109     Document Type: Note

References (29)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
2. Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe MC, Kohler B, et al. Cancer Incidence in Five Continents: inclusion criteria, highlights from volume X and the global status of cancer registration. Int J Cancer 2015;137:2060-71.
3. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends - an update. Cancer Epidemiol Biomarkers Prev 2016;25:16-27.
4. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012;13:790-801.
5. Bray F, Jemal A, Torre LA, Forman D, Vineis P. Long-term realism and cost-effectiveness: primary prevention in combatting cancer and associated inequalities worldwide. J Natl Cancer Inst 2015;107:pii: djv273.
6. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund Q 1971;49:509-38.
7. Caldwell JC. Population health in transition. Bull World Health Organ 2001;79:159-60.
8. Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev 2014;23:953-66.
9. Bray F, Lortet-Tieulent J, Znaor A, Brotons M, Poljak M, Arbyn M. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia. Vaccine 2013;31:H32-45.
10. Moore SP, Antoni S, Colquhoun A, Healy B, Ellison-Loschmann L, Potter JD, et al. Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study. Lancet Oncol 2015;16:1483-92.
11. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.
12. MacMahon B, Pugh H. Epidemiology: principles and methods. Philadelphia: Lippincott Willams and Wilkins; 1970.
13. Tomatis L. Cancer causes, occurrence, and control. Lyon: International Agency for Research on Cancer Scientific Publications No. 100; 1990.
14. Coleman MP, Estève J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality (IARC Scientific Publications, No. 121). Lyon: IARC; 1993.
15. Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99:1881-7.
16. Vaccarella S, Dal ML, Laversanne M, Bray F, Plummer M, Franceschi S. The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 2015;25:1127-36.
17. Esteve J. International study of time trends. Some methodological considerations. Ann N Y Acad Sci USA 1990;609:77-84.
18. Muir CS, Fraumeni-JF J, Doll R. The interpretation of time trends. Cancer Surveys 1994;19/20:5-21.
19. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 1987;6:469-81.
20. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 1987;6:449-67.
21. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Ann Rev Public Health 1991;12:425-57.
22. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983;39:311-24.
23. Korteweg R. The age curve in lung cancer. Br J Cancer 1951;5:21-7.
24. Case RAM. Cohort analysis of mortality rates as an historical or narrative technique. Br J Prev Soc Med 1956;10:159-71.
25. MacMahon B. Breast cancer at menopausal ages: an explanation of observed incidence changes. Cancer 1957;10:1037-44.
26. Barrett JC. The redundant factor method and bladder cancer mortality. J Epidemiol Community Health 1978;32:314-6.
27. Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet 1974;1:1037-40.
28. Moller H. Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 1989;81:1668-9.
29. Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, et al. Planning and developing population-based cancer registration in low- and middle-income settings. Lyon: International Agency for Research on Cancer (IARC Technical Publication No. 43); 2014.